Raymond James analyst Danielle Brill initiates coverage on Agios Pharmaceuticals (NASDAQ:AGIO) with a Market Perform rating.
Raymond James Initiates Coverage On Agios Pharmaceuticals with Market Perform Rating
Raymond James analyst Danielle Brill initiates coverage on Agios Pharmaceuticals (NASDAQ:AGIO) with a Market Perform rating.